NFKB1 and cancer: In this context, the ability of the compounds erioflorin and erioflorin acetate to inhibit the NF-κB signaling pathway, which is overexpressed in DU-145 cancer cells and plays a pivotal role in carcinogenesis, was evaluated [57].